Dr. Dr. Alex Kim

Get to Know Dr. Alex Kim

Dr. Alex Kim is a surgical oncologist and assistant professor of Surgery at UT Southwestern Medical Center in Dallas. He directs the Peritoneal Surface Malignancy and HIPEC Program at the Harold C. Simmons Comprehensive Cancer Center, the only NCI-designated Comprehensive Cancer Center in North Texas. Dr. Kim is board certified in general surgery and complex general surgical oncology and holds both an M.D. and Ph.D.

Dr. Kim specializes in cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy, an advanced treatment for cancers like peritoneal mesothelioma that have spread within the abdominal cavity. He completed fellowship training at the University of Pittsburgh Medical Center and runs a translational research lab studying how colorectal cancer spreads to the peritoneum. He serves as principal investigator on multiple clinical trials and co-authored the 2025 national consensus guidelines on peritoneal mesothelioma management.

Close Button

Full Name

Diagnosis Please Select Mesothelioma Asbestosis Lung Cancer No Diagnosis Other Unknown

Zip Code

Email

Phone Number

Preferred Method of Contact Please Select Call Text

Message

Full Name

Get Connected Now

By clicking Get Connected Now, you agree to be contacted by Asbestos.com’s Patient Advocates with health-related information and services via call, text/SMS using an automated dialing platform and/or email at the telephone number and/or email you provided. Std. msg./data rates apply and your consent to such contact/marketing is not required for purchase of services. You also agree to our Privacy Policy and Terms of Service, including the agreement to arbitrate disputes.

Specialties of Dr. Alex Kim

• Appendiceal cancer
• Colorectal peritoneal metastases
• Cytoreductive surgery
• Gastric cancer
•  HIPEC
•  Peritoneal mesothelioma

Dr. Alex Kim’s Experience and Medical Education

• University of Pittsburgh Medical Center (Fellowship)
• University of Michigan Health System (Residency)
• University of Michigan Medical School (M.D.)
•  University of Michigan Hospitals & Health Centers

Awards and Other Recognitions

• American Board of Surgery, Complex General Surgical Oncology
• American Board of Surgery, General Surgery
• Eugene P. Frenkel, M.D. Scholar in Clinical Medicine

Why Choose Dr. Alex Kim for Peritoneal Mesothelioma Care 

Patients choose Dr. Kim for his specialized expertise in treating peritoneal mesothelioma through cytoreductive surgery and HIPEC. This complex procedure involves removing visible tumors from abdominal organs and surfaces, then circulating heated chemotherapy directly through the abdominal cavity to target remaining cancer cells. Dr. Kim has extensive training in this technique and treats patients with various peritoneal surface malignancies, including the rare peritoneal form of mesothelioma.

Dr. Kim’s research background means patients benefit from his knowledge of the latest treatment developments and access to clinical trials testing new approaches. He publishes regularly in leading oncology journals and contributed to establishing national treatment standards for peritoneal mesothelioma. At UT Southwestern’s Simmons Cancer Center, he works with a multidisciplinary team to develop comprehensive treatment plans that may include surgery, chemotherapy and other therapies tailored to each patient’s specific diagnosis and overall health.

Publications of Dr. Alex Kim

• Kim, A. et al. (2026, February 16). ACR Appropriateness Criteria® Staging and Follow-up of Gastric Cancer. Retrieved from https://www.jacr.org/article/S1546-1440(26)00041-4/fulltext
• Kim, A. et al. (2025. December 8). Single-cell resolution spatial analysis of antigen-presenting cancer-associated fibroblast niches. Retrieved from https://www.cell.com/cancer-cell/fulltext/S1535-6108(25)00393-9?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1535610825003939%3Fshowall%3Dtrue
• Kim, A. et al. (2025. September). Risk of peritoneal metastasis following minimally invasive colectomy for locally advanced colon cancer: a systematic review and meta-analysis. Retrieved from https://academic.oup.com/oncolo/article/30/9/oyaf218/8206302
• Kim, A. et al. (2025. April). Systemic Therapy and Surgical Management of Peritoneal Mesothelioma. Retrieved from https://www.surgonc.theclinics.com/article/S1055-3207(24)00088-7/abstract
• Kim, A. et al. (2025. January 8). Long term outcomes associated with the use of perioperative systemic chemotherapy on low grade appendiceal mucinous neoplasms with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Retrieved from https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2024.1456920/full